Citadel Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Citadel Advisors’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-48,000	Closed	-$1.72M	–	9237
2014 Q4	$1.72M	Sell	48,000 -9,600	-17%	-$287K	﹤0.01%	3102
2014 Q3	$1.5M	Buy	57,600 +12,700	+28%	+$365K	﹤0.01%	3206
2014 Q2	$1.48M	Sell	44,900 -8,300	-16%	-$240K	﹤0.01%	3036
2014 Q1	$1.59M	Sell	53,200 -20,300	-28%	-$700K	﹤0.01%	2882
2013 Q4	$2.23M	Buy	73,500 +40,300	+121%	+$1.11M	﹤0.01%	2439
2013 Q3	$1.06M	Buy	33,200 +11,000	+50%	+$252K	﹤0.01%	3053
2013 Q2	$335K	Buy	+22,200	New	+$308K	﹤0.01%	4198

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors's NPSP Position: Q4 2014 in Review

Citadel Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2014, closing a stake of 47,731 shares — an estimated $1.42M sold.

Citadel Advisors first reported a position in NPSP in Q2 2013 and held it in 6 quarters. The position peaked at $10.7M in Q1 2014. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

Citadel Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
Citadel Advisors sold 47,731 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $1.42M.
Citadel Advisors first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
Citadel Advisors's NPS PHARMACEUTICALS INC position peaked at $10.7M in Q1 2014.
213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.